Literature DB >> 104335

Naloxone-reversible analgesic action of SKF 525-A in mice.

T Lehman, G R Peterson.   

Abstract

SKF 525-A, given i.p. to mice at doses from 50 to 100 mg/kg, had analgesic activity approximately 40% the analgesic potency of d-propoxyphene HCl, a chemically similar narcotic. While the analgesia produced by propoxyphene was totally antagonized by naloxone, however, that produced by SKF 525-A was only partly reversed. We suspect that SKF 525-A may exert its antinociceptive actions partly by an interaction with CNS narcotic receptors and partly by a nonspecific sedating action.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104335     DOI: 10.1007/bf00426639

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

2.  The effect of beta-diethylaminoethyl-diphenylpropylacetate hydrochloride (SKF No. 525-A) on hexobarbital.

Authors:  L COOK; J J TONER; E J FELLOWS
Journal:  J Pharmacol Exp Ther       Date:  1954-06       Impact factor: 4.030

3.  Inhibitory effects of beta-diethylaminoethyl diphenylpropylacetate on a variety of drug metabolic pathways in vitro.

Authors:  J R COOPER; J AXELROD; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030

4.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

5.  Activation of hydrocortisone-induced tryptophan pyrrolase of rat liver by SKF 525-A. The possible involvement of antidiuretic hormone.

Authors:  R D Magus; D E Rickert; J R Fouts
Journal:  Biochem Pharmacol       Date:  1968-10       Impact factor: 5.858

6.  The opiate receptor.

Authors:  S H Snyder; C B Pert; G W Pasternak
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

Review 7.  Enhancement and inhibition of drug metabolism.

Authors:  M W Anders
Journal:  Annu Rev Pharmacol       Date:  1971       Impact factor: 13.820

8.  Toxicity of beta-diethylaminoethyl diphenylpropylacetate (SKF-525A) in cats.

Authors:  B B Gaitondé; H L Borison
Journal:  Toxicol Appl Pharmacol       Date:  1966-01       Impact factor: 4.219

9.  Nitrous oxide "analgesia": resemblance to opiate action.

Authors:  B A Berkowitz; S H Ngai; A D Finck
Journal:  Science       Date:  1976-11-26       Impact factor: 47.728

10.  Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites.

Authors:  L Terenius; A Wahlström; H Agren
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

View more
  2 in total

1.  SKF-525A on schedule-controlled responding: not antagonized by naloxone.

Authors:  J D Leander
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.

Authors:  Lindsay B Hough; Julia W Nalwalk; James G Phillips; Brian Kern; Zhixing Shan; Mark P Wentland; Iwan J P de Esch; Elwin Janssen; Travis Barr; Rebecca Stadel
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.